Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 5
1966 2
1967 6
1968 8
1969 6
1970 3
1971 2
1974 1
1975 1
1976 3
1977 8
1979 2
1980 6
1981 4
1982 3
1983 3
1985 4
1986 2
1987 11
1988 4
1989 5
1990 7
1991 5
1992 5
1993 5
1994 5
1995 2
1996 4
1997 8
1998 5
1999 2
2000 9
2001 7
2002 2
2004 5
2005 3
2006 10
2007 7
2008 2
2009 4
2010 3
2011 11
2012 6
2013 8
2014 13
2015 7
2016 11
2017 14
2018 10
2019 21
2020 15
2021 16
2022 17
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

336 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
Wakita S, Sakaguchi M, Oh I, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Tajika K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Kayamori K, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Arai K, Kitano T, Miyata M, Kurosawa A, Mizoguchi A, Komatsu N, Fukuda T, Ohashi K, Kanda Y, Inokuchi K, Yamaguchi H. Wakita S, et al. Among authors: muto h. Blood Adv. 2022 Jan 11;6(1):238-247. doi: 10.1182/bloodadvances.2021004292. Blood Adv. 2022. PMID: 34448807 Free PMC article.
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia.
Wakita S, Marumo A, Morita K, Kako S, Toya T, Najima Y, Doki N, Kanda J, Kuroda J, Mori S, Satake A, Usuki K, Ueki T, Uoshima N, Kobayashi Y, Kawata E, Nakayama K, Nagao Y, Shono K, Shibusawa M, Tadokoro J, Hagihara M, Uchiyama H, Uchida N, Kubota Y, Kimura S, Nagoshi H, Ichinohe T, Kurosawa S, Motomura S, Hashimoto A, Muto H, Sato E, Ogata M, Mitsuhashi K, Ando J, Tashiro H, Sakaguchi M, Yui S, Arai K, Kitano T, Miyata M, Arai H, Kanda M, Itabashi K, Fukuda T, Kanda Y, Yamaguchi H. Wakita S, et al. Among authors: muto h. Cancer Sci. 2023 Apr;114(4):1297-1308. doi: 10.1111/cas.15720. Epub 2023 Jan 27. Cancer Sci. 2023. PMID: 36610002 Free PMC article.
A fluorogenic probe for core-fucosylated glycan-preferred ENGase.
Ishii N, Muto H, Nagata M, Sano K, Sato I, Iino K, Matsuzaki Y, Katoh T, Yamamoto K, Matsuo I. Ishii N, et al. Among authors: muto h. Carbohydr Res. 2023 Jan;523:108724. doi: 10.1016/j.carres.2022.108724. Epub 2022 Nov 17. Carbohydr Res. 2023. PMID: 36435009
Hard template synthesis of metal nanowires.
Kawamura G, Muto H, Matsuda A. Kawamura G, et al. Among authors: muto h. Front Chem. 2014 Nov 17;2:104. doi: 10.3389/fchem.2014.00104. eCollection 2014. Front Chem. 2014. PMID: 25453031 Free PMC article. Review.
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.
Naoe T, Saito A, Hosono N, Kasahara S, Muto H, Hatano K, Ogura M, Masunari T, Tanaka M, Usuki K, Ishikawa Y, Ando K, Kondo Y, Takagi Y, Takada S, Ishikawa M, Choi I, Sano A, Nagai H. Naoe T, et al. Among authors: muto h. Cancer Immunol Immunother. 2023 Aug;72(8):2865-2871. doi: 10.1007/s00262-023-03432-4. Epub 2023 Apr 24. Cancer Immunol Immunother. 2023. PMID: 37093243 Free PMC article. Clinical Trial.
Quantitative 31P-NMR for Purity Determination of Sofosbuvir and Method Validation.
Uchiyama N, Kiyota K, Hosoe J, Komatsu T, Sugimoto N, Ishizuki K, Koide T, Murabayashi M, Kobayashi K, Fujimine Y, Yokose T, Ofuji K, Shimizu H, Hasebe T, Asai Y, Ena E, Kikuchi J, Fujita K, Makino Y, Iwamoto Y, Miura T, Muto Y, Asakura K, Suematsu T, Muto H, Kohama A, Goto T, Yasuda M, Ueda T, Goda Y. Uchiyama N, et al. Among authors: muto h. Chem Pharm Bull (Tokyo). 2022 Dec 1;70(12):892-900. doi: 10.1248/cpb.c22-00639. Epub 2022 Oct 12. Chem Pharm Bull (Tokyo). 2022. PMID: 36223954 Free article.
336 results